G1 reports Phase Ib data for G1T38 in breast cancer

G1 Therapeutics Inc. (NASDAQ:GTHX) reported preliminary data from 24 estrogen receptor-positive, HER2-negative breast cancer patients in the Phase Ib portion

Read the full 206 word article

User Sign In